Lipitor and Crestor slow coronary artery disease, and here come the generics. Nov. 15, 2011— -- Two top-selling statins, Lipitor and Crestor, are equally effective in treating coronary artery ...
MIAMI (CBS4) – Cheaper generic versions of the popular cholesterol lowering drug Lipitor will soon be hitting the market. The Food and Drug Administration only gives pharmaceutical companies exclusive ...
The late great Joan Rivers once joked about snorting Lipitor before hitting the stage. That should give you an idea of just how thoroughly this cholesterol medication has infiltrated the mainstream.
Some 8.7 million Americans take Lipitor for high cholesterol. Starting Wednesday, they might get a different-looking pill when they go to fill a prescription and pay much less for it. That's the day ...
lower cholesterol levels in adults and some children reduce the risk of heart and blood vessel problems caused by high cholesterol, such as heart attack and stroke, in adults reduce the need for ...
Lipitor is the most prescribed name-brand drug in America — nearly 3.5 million people take it every day to control their cholesterol. Since the statin entered the market in 1997, it’s earned New ...
Today, the U.S. patent expires on the Pfizer’s Lipitor, the best-selling drug of all time. The first generic versions will go for sale, marking the end of a brand that has dominated the drug industry, ...
Pfizer reportedly wants to sell non-prescription version of blockbuster drug. Aug. 4, 2011— -- Could the blockbuster cholesterol-lowering drug Lipitor soon be available without a prescription?
A war brewing over Lipitor could affect your pocketbook whether or not you take the best-selling cholesterol-lowering pill. Last December, Pfizer, the world’s largest drug company, launched a coupon ...
Ranbaxy Laboratories Ltd. has recalled more than 40 lots of its generic version of the cholesterol-lowering drug Lipitor from the U.S. market after finding batches containing small glass particles.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results